Logo image of SLS.CA

SOLARIS RESOURCES INC (SLS.CA) Stock Fundamental Analysis

TSX:SLS - Toronto Stock Exchange - CA83419D2014 - Common Stock - Currency: CAD

6.19  -0.19 (-2.98%)

Fundamental Rating

1

Overall SLS gets a fundamental rating of 1 out of 10. We evaluated SLS against 808 industry peers in the Metals & Mining industry. SLS has a bad profitability rating. Also its financial health evaluation is rather negative. SLS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year SLS has reported negative net income.
SLS had a negative operating cash flow in the past year.
In the past 5 years SLS always reported negative net income.
SLS had a negative operating cash flow in each of the past 5 years.
SLS.CA Yearly Net Income VS EBIT VS OCF VS FCFSLS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

SLS has a worse Return On Assets (-199.39%) than 81.50% of its industry peers.
Industry RankSector Rank
ROA -199.39%
ROE N/A
ROIC N/A
ROA(3y)-117.73%
ROA(5y)-95.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SLS.CA Yearly ROA, ROE, ROICSLS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SLS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLS.CA Yearly Profit, Operating, Gross MarginsSLS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024

1

2. Health

2.1 Basic Checks

The number of shares outstanding for SLS has been increased compared to 1 year ago.
The number of shares outstanding for SLS has been increased compared to 5 years ago.
Compared to 1 year ago, SLS has a worse debt to assets ratio.
SLS.CA Yearly Shares OutstandingSLS.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SLS.CA Yearly Total Debt VS Total AssetsSLS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

SLS has an Altman-Z score of -9.46. This is a bad value and indicates that SLS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -9.46, SLS is not doing good in the industry: 70.41% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -9.46
ROIC/WACCN/A
WACCN/A
SLS.CA Yearly LT Debt VS Equity VS FCFSLS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

SLS has a Current Ratio of 1.71. This is a normal value and indicates that SLS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.71, SLS perfoms like the industry average, outperforming 52.90% of the companies in the same industry.
A Quick Ratio of 1.69 indicates that SLS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.69, SLS is in line with its industry, outperforming 54.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.69
SLS.CA Yearly Current Assets VS Current LiabilitesSLS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1

3. Growth

3.1 Past

SLS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.89%.
EPS 1Y (TTM)-88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, SLS will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.79% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y24.42%
EPS Next 2Y10.62%
EPS Next 3Y22.43%
EPS Next 5Y15.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SLS.CA Yearly Revenue VS EstimatesSLS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 500M 1B 1.5B 2B
SLS.CA Yearly EPS VS EstimatesSLS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5 2

1

4. Valuation

4.1 Price/Earnings Ratio

SLS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SLS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLS.CA Price Earnings VS Forward Price EarningsSLS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLS.CA Per share dataSLS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.2 -0.4 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as SLS's earnings are expected to grow with 22.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.62%
EPS Next 3Y22.43%

0

5. Dividend

5.1 Amount

SLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SOLARIS RESOURCES INC

TSX:SLS (6/27/2025, 7:00:00 PM)

6.19

-0.19 (-2.98%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-06 2025-08-06
Inst Owners30.61%
Inst Owner ChangeN/A
Ins Owners37.34%
Ins Owner ChangeN/A
Market Cap1.01B
Analysts78.18
Price Target12.67 (104.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.7%
Min EPS beat(2)-53.31%
Max EPS beat(2)-6.09%
EPS beat(4)0
Avg EPS beat(4)-46.08%
Min EPS beat(4)-71.62%
Max EPS beat(4)-6.09%
EPS beat(8)4
Avg EPS beat(8)-14.81%
EPS beat(12)4
Avg EPS beat(12)-16.03%
EPS beat(16)4
Avg EPS beat(16)-19.84%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.63%
PT rev (3m)1.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.46%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.85%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS0
BVpS-0.26
TBVpS-0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -199.39%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-117.73%
ROA(5y)-95.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 294.27%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.69
Altman-Z -9.46
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)130.31%
Cap/Depr(5y)354.42%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
EPS Next Y24.42%
EPS Next 2Y10.62%
EPS Next 3Y22.43%
EPS Next 5Y15.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-82.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year7.46%
EBIT Next 3Y17.48%
EBIT Next 5Y38.54%
FCF growth 1Y-25.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.73%
OCF growth 3YN/A
OCF growth 5YN/A